CPIX - Cumberland Pharmaceuticals Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Nashville,
United States
Type: Equity
CPIX price evolution
CPIX
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17.34 | $18.55 | $18.32 | $18.51 |
| Short term investments | ||||
| Net receivables | $11.62 | $10.65 | $9.76 | $12.62 |
| Inventory | $16.17 | $17.24 | $17.41 | $16.97 |
| Total current assets | $35.58 | $36.21 | $35.71 | $41.77 |
| Long term investments | ||||
| Property, plant & equipment | $6.7 | $6.89 | $7.04 | $7.09 |
| Goodwill & intangible assets | $21.37 | $22.44 | $23.52 | $28.04 |
| Total noncurrent assets | $42.94 | $45.3 | $46.06 | $45.98 |
| Total investments | ||||
| Total assets | $78.52 | $81.51 | $81.78 | $87.75 |
| Current liabilities | ||||
| Accounts payable | $12.51 | $13.08 | $14.04 | $10.82 |
| Deferred revenue | ||||
| Short long term debt | $0.38 | $0.36 | $0.35 | $0.33 |
| Total current liabilities | $24.76 | $26.43 | $27.98 | $27.33 |
| Long term debt | $21.19 | $21.28 | $18.08 | $18.31 |
| Total noncurrent liabilities | $27.73 | $27.89 | $24.53 | $24.77 |
| Total debt | $21.57 | $21.65 | $18.43 | $18.65 |
| Total liabilities | $52.49 | $54.32 | $52.52 | $52.1 |
| Shareholders' equity | ||||
| Retained earnings | -$20.52 | -$19.43 | -$17.49 | -$11.19 |
| Other shareholder equity | ||||
| Total shareholder equity | $26.35 | $27.49 | $29.6 | $35.99 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $18.32 | $19.76 | $27.04 | $24.75 |
| Short term investments | ||||
| Net receivables | $9.76 | $13.16 | $6.88 | $12.38 |
| Inventory | $17.41 | $9.86 | $17.48 | $22.29 |
| Total current assets | $35.71 | $45.87 | $45.69 | $49.97 |
| Long term investments | ||||
| Property, plant & equipment | $7.04 | $5.5 | $1.47 | $2.6 |
| Goodwill & intangible assets | $23.52 | $31.5 | $24.84 | $29 |
| Total noncurrent assets | $46.06 | $47.05 | $38.77 | $46.49 |
| Total investments | ||||
| Total assets | $81.78 | $92.93 | $84.46 | $96.46 |
| Current liabilities | ||||
| Accounts payable | $14.04 | $10.82 | $9.64 | $13.4 |
| Deferred revenue | ||||
| Short long term debt | $0.35 | $0.17 | $0.97 | $1.02 |
| Total current liabilities | $27.98 | $28.58 | $19.28 | $25.67 |
| Long term debt | $18.08 | $16.2 | $15.09 | $16.06 |
| Total noncurrent liabilities | $24.53 | $28.37 | $22.58 | $23.92 |
| Total debt | $18.43 | $20.96 | $16.06 | $17.08 |
| Total liabilities | $52.52 | $56.66 | $41.86 | $49.59 |
| Shareholders' equity | ||||
| Retained earnings | -$17.49 | -$11.21 | -$5.64 | -$2.13 |
| Other shareholder equity | -$0.12 | |||
| Total shareholder equity | $29.6 | $36.27 | $42.81 | $46.99 |
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Oct 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8.5 | $9.35 | ||
| Cost of revenue | $1.58 | $1.53 | ||
| Gross Profit | $6.92 | $7.82 | ||
| Operating activities | ||||
| Research & development | $1.16 | $1.26 | ||
| Selling, general & administrative | $6.52 | $8.2 | ||
| Total operating expenses | $8.79 | $14 | ||
| Operating income | -$1.87 | -$6.18 | ||
| Income from continuing operations | ||||
| EBIT | -$1.82 | -$6.09 | ||
| Income tax expense | $0.01 | $0.02 | ||
| Interest expense | $0.12 | $0.18 | ||
| Net income | ||||
| Net income | -$1.95 | -$6.29 | ||
| Income (for common shares) | -$1.95 | -$6.29 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $39.55 | $42.01 | $35.99 | $37.44 |
| Cost of revenue | $6.07 | $9.12 | $8.81 | $8.65 |
| Gross Profit | $33.49 | $32.89 | $27.17 | $28.79 |
| Operating activities | ||||
| Research & development | $5.83 | $6.69 | $5.68 | $5.77 |
| Selling, general & administrative | $29.1 | $26.84 | $24.8 | $24.96 |
| Total operating expenses | $43.04 | $38.6 | $34.85 | $35.17 |
| Operating income | -$9.55 | -$5.7 | -$7.68 | -$6.38 |
| Income from continuing operations | ||||
| EBIT | -$5.57 | -$4.92 | -$3.37 | -$3.02 |
| Income tax expense | $0.05 | $0.07 | $0.03 | $0.06 |
| Interest expense | $0.67 | $0.59 | $0.1 | $0.26 |
| Net income | ||||
| Net income | -$6.28 | -$5.57 | -$3.51 | -$3.34 |
| Income (for common shares) | -$6.28 | -$5.57 | -$3.51 | -$3.34 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$1.09 | -$1.95 | -$6.29 | -$1.05 |
| Operating activities | ||||
| Depreciation | $1.42 | $1.44 | $2.07 | $1.25 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.07 | $0.08 | $0.09 | $0.08 |
| Total cash flows from operations | -$0.86 | -$2.14 | $1.04 | $1.24 |
| Investing activities | ||||
| Capital expenditures | -$0.05 | -$0.06 | -$0.09 | -$0.1 |
| Investments | ||||
| Total cash flows from investing | -$0.05 | -$0.06 | $0.26 | -$0.1 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.13 | -$0.25 | -$0.19 | -$0.2 |
| Net borrowings | $0.01 | $3.3 | -$0.14 | -$0.23 |
| Total cash flows from financing | -$0.31 | $2.42 | -$1.49 | -$0.88 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$1.21 | $0.23 | -$0.19 | $0.26 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$6.28 | -$5.57 | -$3.51 | -$3.34 |
| Operating activities | ||||
| Depreciation | $5.77 | $5.33 | $4.61 | $4.75 |
| Business acquisitions & disposals | -$12.5 | |||
| Stock-based compensation | $0.37 | $0.45 | $0.74 | $1.05 |
| Total cash flows from operations | $6.09 | $8.45 | $6.34 | $5.42 |
| Investing activities | ||||
| Capital expenditures | -$0.45 | -$2.07 | -$0.35 | -$2.11 |
| Investments | -$0.2 | |||
| Total cash flows from investing | -$0.11 | -$13.67 | -$0.5 | -$1.76 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.74 | -$1.05 | -$1.39 | -$1.85 |
| Net borrowings | -$3.42 | $1.2 | -$3.51 | |
| Total cash flows from financing | -$7.42 | -$2.06 | -$3.55 | -$7.12 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$1.44 | -$7.28 | $2.29 | -$3.46 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.77 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.44 |
| Quick ratio | 0.78 |